Cubist Systematic Strategies, LLC Vertex Pharmaceuticals Inc Put Options Transaction History

Cubist Systematic Strategies, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	SELL	$343.0 - $410.68 $12.5 Million - $14.9 Million	-36,300 Reduced 99.45%	200 $81,000
Q3 2023 Nov 14, 2023	BUY	$338.18 - $362.46 $7.3 Million - $7.83 Million	21,600 Added 144.97%	36,500 $12.7 Million
Q2 2023 Aug 14, 2023	BUY	$314.42 - $351.91 $4.68 Million - $5.24 Million	14,900 New	14,900 $5.24 Million
Q4 2022 Feb 14, 2023	SELL	$285.76 - $321.48 $2.26 Million - $2.54 Million	-7,900 Reduced 49.69%	8,000 $2.31 Million
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $4.35 Million - $4.86 Million	15,900 New	15,900 $4.6 Million

1,717

222M

1.5M

1.31M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $124B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.